Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 6,950 | 5,086 | 0 | 2,192 | 1,881 |
| Operating Income | -6,950 | -5,086 | N/A | -2,192 | -1,881 |
| Other Income | 175 | 139 | 0 | 112 | 1 |
| Pre-tax Income | -6,775 | -4,947 | 0 | -2,080 | -1,880 |
| Net Income Continuous | -6,775 | -4,947 | N/A | -2,080 | -1,880 |
| Net Income | $-6,775 | $-4,947 | $N/A | $-2,080 | $-1,880 |
| EPS Basic Total Ops | -33.10 | -65.30 | N/A | -33.10 | -33.00 |
| EPS Basic Continuous Ops | -33.15 | -65.35 | N/A | -33.12 | -33.04 |
| EPS Diluted Total Ops | -33.10 | -65.30 | N/A | -33.10 | -33.00 |
| EPS Diluted Continuous Ops | -33.15 | -65.35 | N/A | -33.12 | -33.04 |
| EBITDA(a) | $-6,756 | $-4,999 | $N/A | $-2,149 | $-1,881 |